Carrie Stearns

Carrie Stearns, Ph.D., currently serves as the Vice President of US Marketing at Rezolute, Inc., focusing on transformative therapies for rare diseases. In addition to this role, Carrie is a Board Member at The XLH Network, Inc. Previously, Carrie held senior positions in oncology marketing at Corcept Therapeutics and led marketing and commercial strategy at Cognoa, where the first FDA-authorized AI/ML digital diagnostic aid for autism was developed. Carrie's extensive experience includes global marketing strategy at Astellas Gene Therapies, leading marketing initiatives for Ultragenyx Pharmaceutical's breakthrough therapy CRYSVITA, and driving HCP marketing for Crescendo Bioscience's Vectra DA. Educational qualifications include a Ph.D. in Chemistry and Chemical Biology from Cornell University, an MBA in Marketing from the UW Foster School of Business, and a Master of Science in Organic Chemistry from Cornell University.